1. Home
  2. MDGL vs LRN Comparison

MDGL vs LRN Comparison

Compare MDGL & LRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDGL
  • LRN
  • Stock Information
  • Founded
  • MDGL 2011
  • LRN 2000
  • Country
  • MDGL United States
  • LRN United States
  • Employees
  • MDGL N/A
  • LRN N/A
  • Industry
  • MDGL Biotechnology: Pharmaceutical Preparations
  • LRN Other Consumer Services
  • Sector
  • MDGL Health Care
  • LRN Real Estate
  • Exchange
  • MDGL Nasdaq
  • LRN Nasdaq
  • Market Cap
  • MDGL 6.1B
  • LRN 5.9B
  • IPO Year
  • MDGL N/A
  • LRN 2007
  • Fundamental
  • Price
  • MDGL $414.68
  • LRN $165.21
  • Analyst Decision
  • MDGL Strong Buy
  • LRN Buy
  • Analyst Count
  • MDGL 8
  • LRN 5
  • Target Price
  • MDGL $445.71
  • LRN $143.40
  • AVG Volume (30 Days)
  • MDGL 469.6K
  • LRN 774.4K
  • Earning Date
  • MDGL 08-05-2025
  • LRN 08-05-2025
  • Dividend Yield
  • MDGL N/A
  • LRN N/A
  • EPS Growth
  • MDGL N/A
  • LRN 26.87
  • EPS
  • MDGL N/A
  • LRN 5.95
  • Revenue
  • MDGL $515,547,000.00
  • LRN $2,405,317,000.00
  • Revenue This Year
  • MDGL $286.67
  • LRN $8.01
  • Revenue Next Year
  • MDGL $67.98
  • LRN $8.16
  • P/E Ratio
  • MDGL N/A
  • LRN $27.76
  • Revenue Growth
  • MDGL 3421.98
  • LRN 17.90
  • 52 Week Low
  • MDGL $200.63
  • LRN $63.25
  • 52 Week High
  • MDGL $419.99
  • LRN $169.87
  • Technical
  • Relative Strength Index (RSI)
  • MDGL 77.54
  • LRN 73.00
  • Support Level
  • MDGL $351.32
  • LRN $140.53
  • Resistance Level
  • MDGL $393.76
  • LRN $164.41
  • Average True Range (ATR)
  • MDGL 17.32
  • LRN 5.62
  • MACD
  • MDGL 6.15
  • LRN 2.18
  • Stochastic Oscillator
  • MDGL 94.95
  • LRN 88.91

About MDGL Madrigal Pharmaceuticals Inc.

Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, and premature mortality. The company's medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor agonist designed to target key underlying causes of MASH.

About LRN Stride Inc.

Stride Inc is an American online educational company. It offers alternative programs to traditional on-campus schooling. It also operates state-funded virtual charter schools around the United States. The educational programs for K-12 students are usually monitored by parents and provide virtual classroom environments where teachers meet with students online, by phone, or in-person. The company's contractual agreements with various school districts to offer its curriculum programs provide a majority of the company's revenue. The company lines of business are Managed Public School Programs, Institutional, and Private Pay Schools and Other.

Share on Social Networks: